PDXen Information

Companies that develop multiple omics-based patient management systems. ● Based on the genome analysis and biological characteristics of blood cancer cells, which are direct causative cells of cancer metastasis, we are establishing micro cancer metastatic cancer prediction and anticancer screening system. ● Developed a machine-learning-based algorithm to predict patient progression. ● Drug susceptibility analysis system selected through cell drug reaction using real-time cell tracking system for biological characterization of disease-related cells. We Do Service and Make Products. # Realtime Cell Tracking System # Monitoring System for Minimal Residual Disease # Patient Care Service based on PHR # Patient-derived Xenograft Model Service for Cancer Progression # Genetic and Microbiome Screening Service